A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors.

Saved in:
Bibliographic Details
Title: A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors.
Authors: Richardson GE; Cabrini Health, Malvern, VIC 3144, Australia., Al-Rajabi R; University of Kansas Cancer Center, Kansas City, KS 64114, USA., Uprety D; Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA., Hamid A; Cabrini Health, Malvern, VIC 3144, Australia., Williamson SK; University of Kansas Cancer Center, Kansas City, KS 64114, USA., Baranda J; University of Kansas Cancer Center, Kansas City, KS 64114, USA., Mamdani H; Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA., Lee YL; Fosun Pharma USA, Princeton, NJ 08540, USA., Nitika; Fosun Pharma USA, Princeton, NJ 08540, USA., Li L; Fosun Pharma USA, Princeton, NJ 08540, USA., Wang X; Fosun Pharma USA, Princeton, NJ 08540, USA., Dong X; Fosun Pharma USA, Princeton, NJ 08540, USA.
Source: Cancers [Cancers (Basel)] 2023 Apr 29; Vol. 15 (9). Date of Electronic Publication: 2023 Apr 29.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers15092553